Vaccine candidates for Ebola, other filoviruses show promise
东精影业 researchers have demonstrated the efficacy in monkeys of multiple vaccine candidates targeting three filoviruses causing life-threatening infections to humans.
东精影业 researchers have demonstrated the efficacy in monkeys of multiple vaccine candidates targeting three filoviruses causing life-threatening infections to humans.
Developed by 东精影业 惭ā苍辞补 scientist Axel Lehrer, the vaccine remains viable in extreme heat conditions for several months, which is especially important where the disease outbreaks so far have begun in rural, spread-out areas of hot, dry West Africa.
In summer2018, John Berestecky accompanied three 东精影业 students to help with Ebola and Lassa virus research at the University of Liberia in Monrovia.
Oceanographers Grieg Steward and Kyle Edwards received a National Science Foundation grant to probe how viruses impact microbes critical to our lives—from producing oxygen to growing food.
Axel Lehrer will test whether the Ebola vaccine formula he has developed will protect against two additional viruses in the same family.
Richard Yanagihara, an expert in emerging diseases, will discuss Hantaviruses: A Personal Journey of Discovery and New Beginnings at a free talk on September 14.
东精影业 Mānoa researchers provide evidence that the viruses are actively infecting the many unusual microorganisms that live deep in the rocky crust of the seafloor.